Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
China flag China · Delayed Price · Currency is CNY
23.87
+0.30 (1.27%)
Nov 6, 2026, 3:00 PM CST

SHA:600285 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
761.76382.841,2281,4991,179801.24
Short-Term Investments
-547.59283.0195.63125.34140.77
Trading Asset Securities
261.09160.35-0.21150.42280.19
Cash & Short-Term Investments
1,0231,0911,5111,5951,4551,222
Cash Growth
-24.76%-27.83%-5.23%9.60%19.05%47.32%
Accounts Receivable
984.11713.34488.95498.99511.97431.18
Other Receivables
11.597.16.2919.3521.379.58
Receivables
995.69720.44495.23518.34533.34440.77
Inventory
363.04436.64434.97467.35486.41428.39
Other Current Assets
810.3632.0216.4518.5133.5839.87
Total Current Assets
3,1922,2802,4582,5992,5082,131
Property, Plant & Equipment
698.88682.62631.2647.81706.76732.92
Long-Term Investments
257.931,5701,4371,069676.63364.7
Goodwill
482.02482.02----
Other Intangible Assets
332.51330.14203.75202.5203.65236.95
Long-Term Deferred Tax Assets
263.03198.35199.59186.92159.2116.49
Long-Term Deferred Charges
20.4818.5412.3436.7351.5465.53
Other Long-Term Assets
927.7973.4874.4529.9838.45145.25
Total Assets
6,1755,6365,0174,7724,3453,793

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
88.4897.2785.1357.3868.0278.01
Accrued Expenses
161.051,1211,1761,110917.79600.38
Short-Term Debt
317.64409.5290.47199.94151.15272.34
Current Portion of Long-Term Debt
1.3-----
Current Portion of Leases
-2.591.781.081.221.65
Current Income Taxes Payable
225.9649.8156.2870.7255.5446.9
Current Unearned Revenue
57.6883.64114.28114.48153.7579.09
Other Current Liabilities
1,747352.12350.24346.95364.47359.28
Total Current Liabilities
2,5992,1161,8741,9001,7121,438
Long-Term Leases
3.44.276.556.966.27.9
Long-Term Unearned Revenue
33.993133.439.7838.5542.78
Long-Term Deferred Tax Liabilities
40.4348.7422.2726.3229.5618.18
Total Liabilities
2,6772,2001,9371,9731,7861,507

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
567.12567.12567.12567.14567.46567.76
Additional Paid-In Capital
373.23367.2340.61326.23309.82272.02
Retained Earnings
2,5332,4382,1811,8941,6641,481
Treasury Stock
-5.6-12.58-13.7-47.4-67.62-98.19
Comprehensive Income & Other
-10.3840.41-2.025176.7456.08
Total Common Equity
3,4583,4013,0732,7912,5512,279
Minority Interest
40.0235.337.777.667.557.59
Shareholders' Equity
3,4983,4363,0802,7992,5582,287
Total Liabilities & Equity
6,1755,6365,0174,7724,3453,793

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
322.33416.3898.8207.99158.57281.89
Net Cash (Debt)
700.52674.411,4131,3871,296940.31
Net Cash Growth
-16.04%-52.26%1.86%6.96%37.88%41.69%
Net Cash Per Share
1.241.192.502.452.281.66
Filing Date Shares Outstanding
566.36566.13564.42563.94569.61564.55
Total Common Shares Outstanding
566.36566.13564.42563.94569.61564.55
Working Capital
592.97164.31583.7698.77796.44693.59
Book Value Per Share
6.116.015.444.954.484.04
Tangible Book Value
2,6432,5882,8692,5892,3472,042
Tangible Book Value Per Share
4.674.575.084.594.123.62
Buildings
-659.16588.03593.96595.01582.83
Machinery
-672.16591.9581.63581.92534.7
Construction In Progress
-16.0134.22.881.9224.78